RAPT Therapeutics, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
RAPT Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • RAPT Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -89.1 %, a 71.5% decline year-over-year.
  • RAPT Therapeutics, Inc. annual Return On Equity for 2023 was -63.1 %, a 51.5% decline from 2022.
  • RAPT Therapeutics, Inc. annual Return On Equity for 2022 was -41.7 %, a 5.04% decline from 2021.
  • RAPT Therapeutics, Inc. annual Return On Equity for 2021 was -39.7 %, a 12.1% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -63.1 -21.5 -51.5% Jan 1, 2023 Dec 31, 2023
2022 -41.7 -2 -5.04% Jan 1, 2022 Dec 31, 2022
2021 -39.7 +5.44 +12.1% Jan 1, 2021 Dec 31, 2021
2020 -45.1 -108 -172% Jan 1, 2020 Dec 31, 2020
2019 63 +19.7 +45.3% Jan 1, 2019 Dec 31, 2019
2018 43.4 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.